PhaseV Showcases ML-Driven Clinical Trial Innovations at Key Conferences
PhaseV, a leader in software and machine learning (ML) solutions for clinical trial optimization, has announced its participation in five major industry conferences in the first half of 2025. Senior executives will present groundbreaking advancements in causal inference and adaptive ML tools, demonstrating how AI is reshaping clinical development.
